|
|
Article: Research and Markets: With Commitments US$618.7 Million Investment, Examine the the Pharmaceutical Market of Singapore.
- Article from:
- Business Wire
- Article date:
- January 28, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/1e551b/the_pharmaceutical) has announced the addition of the "The Pharmaceutical Market: Singapore" report to their offering.
Singapore is ranked among one of the most open economies in the world, and remains a popular destination for companies using the country as a trading base for the South East Asian region. Incentives such as low corporate tax rates and strong intellectual property laws enabled Singapore to secure S$932.4 million (US$618.7 million) in commitments to invest in the biomedical manufacturing industry (pharmaceutical and medical devices) in 2007 alone. These ...